Revolution Medicines Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 106
Employees
  • Stock Symbol
  • RVMD
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $40.37
  • (As of Friday Closing)

Revolution Medicines General Information

Description

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products include RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 700 Saginaw Drive
  • Redwood City, CA 94063
  • United States

Revolution Medicines Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Revolution Medicines Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$40.37 $39.45 $17.34 - $47.14 $2.66B 65.9M 429K -$2.09

Revolution Medicines Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 1,525,959
Revenue 46,165 50,041 20,165 0
EBITDA (77,236) (50,778) (40,686) (29,941)
Net Income (74,148) (47,664) (41,789) (31,127)
Total Assets 453,957 220,529 170,586 15,077
Total Debt 34,063 172 147 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Revolution Medicines Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Revolution Medicines‘s full profile, request access.

Request a free trial

Revolution Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Revolution Medicines‘s full profile, request access.

Request a free trial

Revolution Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies t
Biotechnology
Redwood City, CA
106 As of 2020
00000
00000000 00000

00000 00

u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
0000000000000
Hayward, CA
000 As of 0000
00000
000000000 00000

000000 0

u fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia d
0000000000000
Cambridge, MA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Revolution Medicines Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arcus Biosciences Formerly VC-backed Hayward, CA 000 00000 000000000 00000
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000 00000000000 Formerly VC-backed Burlingame, CA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
0000000 0000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
You’re viewing 5 of 45 competitors. Get the full list »

Revolution Medicines Executive Team (17)

Name Title Board Seat Contact Info
Mark Goldsmith Ph.D Chief Executive Officer & Board Member
Martin Burke MD Co-Founder & Chairman of Scientific Advisory Board
Steve Kelsey MD President of Research & Development
Margaret Horn JD Chief Operating Officer, Operations & General Counsel, Legal
Michael Fischbach Ph.D Co-Founder & Scientific Advisory Board Member
You’re viewing 5 of 17 executive team members. Get the full list »

Revolution Medicines Board Members (18)

Name Representing Role Since
Alexis Borisy Third Rock Ventures Board Member 000 0000
Barbara Weber MD Third Rock Ventures Board Member 000 0000
Elizabeth Anderson Revolution Medicines Board Member 000 0000
Eric Schmidt Ph.D Self Board Member 000 0000
Laurence Lasky Ph.D Self Board Member 000 0000
You’re viewing 5 of 18 board members. Get the full list »

Revolution Medicines Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revolution Medicines Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000 000 31-Jan-2019 000000000000000000 Drug Discovery 0000 000000000 00.0
To view Revolution Medicines’s complete acquisitions history, request access »